Shuping Li, female, PhD, graduated from Shanghai University of Traditional Chinese Medicine in 2018, is an Associate Research Fellow at the Xinjiang Technical Institute of Physics & Chemistry, Chinese Academy of Sciences. A member of the Youth Innovation Promotion Association of Chinese Academy of Sciences, a member of the Xinjiang Physiological Science Society, a member of the First Committee of the Youth Federation of High-tech Zone (New Urban Area), Urumqi, Xinjiang, and a member of the First Committee of the Science and Technology Association of High-tech Zone (New Urban Area), Urumqi, Xinjiang.
Main research areas and achievements:
She is engaged in the research of quality standards of traditional Chinese medicine and ethnic medicine, new drug research and development, and drug registration.
She has successively obtained 5 clinical approvals for new drugs, including the clinical approval CXZL1900019 for the Class 1 new traditional Chinese medicine "Naizilai Granules" (Phase III clinical trial), the clinical approval 2021LP01651 for the Class 1 new traditional Chinese medicine "Aila Tablets" (Phase II clinical trial), the clinical approval 2024LP00143 for the Class 1 new traditional Chinese medicine "Shabiya Tablets" (Phase II clinical trial), the clinical approval 2024LP01426 for the Class 1 new traditional Chinese medicine "Siyadan Gel", and the clinical approval 2025LP03259 for the Class 1 new traditional Chinese medicine "Mamuranqini Ointment". In addition, 2 more new drugs are in the pre-clinical research stage.
In terms of international scientific and technological cooperation oriented to the "Belt and Road" and overseas transformation of new drug achievements, the Naizilai Granules she participated in the research and development obtained the first clinical approval for innovative traditional Chinese medicine in Uzbekistan, and the registration and clinical research of innovative traditional Chinese medicines such as Aila Tablets and Shabiya Tablets are steadily advancing. The research results provide sufficient scientific basis for promoting the modernization, industrialization and internationalization of traditional Chinese medicine and ethnic medicine.
She has applied for 3 invention patents, 2 of which have been authorized, published more than 20 academic papers, and assisted in training 4 doctoral students and 5 master students.
Honors and awards：
Second Prize of Shanghai Science and Technology Progress Award (2024)
First Prize of Science and Technology Award of China Medical Association of Minorities (2024)
Honorary Title of "Outstanding Science and Technology Worker" of Urumqi Overseas Students Pioneer Park (2019)
Nomination Award for Outstanding Doctoral Dissertation in Traditional Chinese Medicine of China (2019)
Outstanding Graduate of Shanghai (2018)
Representative articles :
1. Shuping Li, Li Chen, Fei He, Tao Wu, Haji Aikebaier Aisa*. Analysis on the quantity-value transfer of the benchmark sample of classical prescription Huanglian Ointment based on HPLC fingerprint and 6 index components[J]. Chinese Traditional and Herbal Drugs, 2025, 56(17): 6196-6206.
2. Shuping Li, Fan Zhou, Fei He. Identification of chemical components in Atirali Honey Pills by UPLC-QTOF-MS/MS[J]. Modern Drugs and Clinic, 2025, 40(11): 2760-2769.
3. Shuping Li, Atikanmu Wahafu, Reyimuguli Abdulla. Pharmacokinetic study of 3 pairs of isomers in Corvitia in beagle dogs based on UPLC-MS/MS[J]. China Journal of Chinese Materia Medica, 2025, 50(24): 7013-7021.
4. SP Li, YW Wang, SL Qi, YP Zhang, G Deng, WZ Ding, C Ma, QY Lin, HD Guan, W Liu, XM Cheng and CH Wang*. Analogous β-carboline alkaloids harmaline and harmine ameliorate scopolamine-induced cognition dysfunction by attenuating acetylcholinesterase activity, oxidative stress, and inflammation in mice. Frontiers in Pharmacology, 2018, 9: 1-16.
5. YW Wang1, SP Li1, LH Zhang, SL Qi, HD Guan, W Liu, XM Cheng, L Liu, L Cheng and CH Wang*. Chemical fingerprint analysis and simultaneous determination of nucleosides and amino acids in Kang Fu Xin Liquid by high performance liquid chromatography with diode array detector. Current Pharmaceutical Analysis, 2019, 16(7): 1-13.
6. Ning Cao, Shuping Li, Aimin Xu, Manlin Li, Xiaoguang Zou, Zunji Ke, Gang Deng, Xuemei Cheng and Changhong Wang. Dynamic changes of endogenic or exogenic β-carboline alkaloid harmine in different mammals and human in vivo at developmental and physiological stats, Frontiers in Aging Neuroscience, 2022, 13: 1-14.
7. Yuying Hu, Shuping Li, Reyimuguli Abdulla, Haji Aikebaier Aisa, Tao Wu*. Analysis on the quantity-value transfer of the benchmark sample of classical prescription Yiguan Jian based on fingerprint and 4 index components[J]. Chinese Traditional and Herbal Drugs, 2023, 54(18): 5880-5891.
8. Fan Zhou, Shuping Li, Fei He, Tao Wu, Haji Aikebaier Aisa, Mawulanjiang Maitinur*. Determination of isochlorogenic acid A, neochlorogenic acid, chlorogenic acid, cryptochlorogenic acid, isochlorogenic acid B and isochlorogenic acid C in Carum carvi L. by one-test multi-evaluation method[J]. Drug Evaluation Research, 2023, 46(4): 703-710.
9. Yahui Yan, Shuping Li, Reyimuguli Abdulla, Haji Aikebaier Aisa*. Establishment of HPLC fingerprint, chemical pattern recognition analysis and content determination of Aloe[J]. Natural Product Research and Development, 2021, 33: 353-361.
10. Yuying Hu, Li Chen, Shuping Li, Haji Aikebaier Aisa, Tao Wu. Historical evolution, modern research progress and quality marker (Q-Marker) prediction analysis of classical prescription Yiguan Jian[J]. Chinese Traditional and Herbal Drugs, 2022, 53, 1-12.
Representative patents :
1. Method for Establishment of HPLC Fingerprints and Determination of Multi-component Contents of Huanglian Ointment, Li Shuping, Ajiakebaier Aisa, Wu Tao, He Fei, Grant No. ZL202310310484.9
2. Method for Preparation of Glycyrrhiza glabra Extract and Use Thereof, He Fei, Xin Xuelei, Wu Tao, Cheng Zhen, Liu Liu, Li Shuping, Grant No. ZL202111287796.X
3. Quality Control Method for Compound Ointment for Treating Eczema, Ajiakebaier Aisa, Li Shuping, Wu Tao, Liu Changhua, Guan Jiawei, Application No. 2024112058488
Research area：
Research on Quality Standards of Traditional Chinese Medicines, Research and Development of New Traditional Chinese and Ethnic Minority Medicines, Registration of Traditional Chinese and Ethnic Minority Medicines
